ATRION CORPORATION (ATRI) Stock Fundamental Analysis
NASDAQ:ATRI - Nasdaq - US0499041053 - Common Stock - Currency: USD
Overall ATRI gets a fundamental rating of 5 out of 10. We evaluated ATRI against 188 industry peers in the Health Care Equipment & Supplies industry. ATRI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ATRI does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year ATRI was profitable.
In the past year ATRI had a positive cash flow from operations.
Each year in the past 5 years ATRI has been profitable.
ATRI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ATRI has a better Return On Assets (4.82%) than 82.72% of its industry peers.
The Return On Equity of ATRI (5.26%) is better than 77.49% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.13%, ATRI is in the better half of the industry, outperforming 78.53% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ATRI is above the industry average of 7.89%.
The 3 year average ROIC (11.35%) for ATRI is well above the current ROIC(5.13%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.82% | ||
| ROE | 5.26% | ||
| ROIC | 5.13% |
ROA(3y)11.02%
ROA(5y)11.82%
ROE(3y)12.05%
ROE(5y)13%
ROIC(3y)11.35%
ROIC(5y)12.04%
1.3 Margins
ATRI has a better Profit Margin (6.92%) than 78.53% of its industry peers.
ATRI's Profit Margin has declined in the last couple of years.
ATRI's Operating Margin of 7.93% is fine compared to the rest of the industry. ATRI outperforms 75.39% of its industry peers.
In the last couple of years the Operating Margin of ATRI has declined.
The Gross Margin of ATRI (32.08%) is worse than 72.25% of its industry peers.
ATRI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.93% | ||
| PM (TTM) | 6.92% | ||
| GM | 32.08% |
OM growth 3Y-18%
OM growth 5Y-13.39%
PM growth 3Y-19.22%
PM growth 5Y-12.62%
GM growth 3Y-6.34%
GM growth 5Y-4.8%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ATRI is still creating some value.
The number of shares outstanding for ATRI has been reduced compared to 1 year ago.
ATRI has less shares outstanding than it did 5 years ago.
ATRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
ATRI has an Altman-Z score of 25.99. This indicates that ATRI is financially healthy and has little risk of bankruptcy at the moment.
ATRI has a better Altman-Z score (25.99) than 95.29% of its industry peers.
There is no outstanding debt for ATRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 25.99 |
ROIC/WACC0.59
WACC8.7%
2.3 Liquidity
ATRI has a Current Ratio of 6.80. This indicates that ATRI is financially healthy and has no problem in meeting its short term obligations.
ATRI has a Current ratio of 6.80. This is amongst the best in the industry. ATRI outperforms 81.68% of its industry peers.
ATRI has a Quick Ratio of 2.94. This indicates that ATRI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.94, ATRI is in the better half of the industry, outperforming 61.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.8 | ||
| Quick Ratio | 2.94 |
3. Growth
3.1 Past
The earnings per share for ATRI have decreased strongly by -53.54% in the last year.
Measured over the past years, ATRI shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.39% on average per year.
The Revenue has been growing slightly by 6.00% in the past year.
ATRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.13% yearly.
EPS 1Y (TTM)-53.54%
EPS 3Y-14.81%
EPS 5Y-9.39%
EPS Q2Q%-93.89%
Revenue 1Y (TTM)6%
Revenue growth 3Y4.68%
Revenue growth 5Y2.13%
Sales Q2Q%11.25%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 64.50, which means the current valuation is very expensive for ATRI.
ATRI's Price/Earnings ratio is a bit cheaper when compared to the industry. ATRI is cheaper than 68.06% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.53. ATRI is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ATRI is valued a bit cheaper than the industry average as 73.82% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ATRI is valued cheaply inside the industry as 84.29% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.25 | ||
| EV/EBITDA | 26.01 |
4.3 Compensation for Growth
ATRI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
ATRI has a Yearly Dividend Yield of 1.91%. Purely for dividend investing, there may be better candidates out there.
ATRI's Dividend Yield is rather good when compared to the industry average which is at 1.89. ATRI pays more dividend than 96.34% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, ATRI has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.91% |
5.2 History
On average, the dividend of ATRI grows each year by 10.99%, which is quite nice.
ATRI has paid a dividend for at least 10 years, which is a reliable track record.
ATRI has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.99%
Div Incr Years20
Div Non Decr Years20
5.3 Sustainability
ATRI pays out 123.31% of its income as dividend. This is not a sustainable payout ratio.
ATRI's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP123.31%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:ATRI (8/20/2024, 8:22:19 PM)
459.92
+0.26 (+0.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners1.01%
Inst Owner Change-45.73%
Ins Owners1.03%
Ins Owner Change0%
Market Cap809.46M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.91% |
Yearly Dividend8.6
Dividend Growth(5Y)10.99%
DP123.31%
Div Incr Years20
Div Non Decr Years20
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.5 | ||
| Fwd PE | N/A | ||
| P/S | 4.46 | ||
| P/FCF | 29.25 | ||
| P/OCF | 20.89 | ||
| P/B | 3.39 | ||
| P/tB | 3.55 | ||
| EV/EBITDA | 26.01 |
EPS(TTM)7.13
EY1.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)15.73
FCFY3.42%
OCF(TTM)22.02
OCFY4.79%
SpS103.18
BVpS135.72
TBVpS129.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.82% | ||
| ROE | 5.26% | ||
| ROCE | 5.93% | ||
| ROIC | 5.13% | ||
| ROICexc | 5.53% | ||
| ROICexgc | 5.81% | ||
| OM | 7.93% | ||
| PM (TTM) | 6.92% | ||
| GM | 32.08% | ||
| FCFM | 15.24% |
ROA(3y)11.02%
ROA(5y)11.82%
ROE(3y)12.05%
ROE(5y)13%
ROIC(3y)11.35%
ROIC(5y)12.04%
ROICexc(3y)13.26%
ROICexc(5y)14.73%
ROICexgc(3y)13.99%
ROICexgc(5y)15.58%
ROCE(3y)13.12%
ROCE(5y)13.92%
ROICexcg growth 3Y-18.15%
ROICexcg growth 5Y-19.86%
ROICexc growth 3Y-17.93%
ROICexc growth 5Y-19.35%
OM growth 3Y-18%
OM growth 5Y-13.39%
PM growth 3Y-19.22%
PM growth 5Y-12.62%
GM growth 3Y-6.34%
GM growth 5Y-4.8%
F-Score6
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 70.13% | ||
| Cap/Sales | 6.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 128.3% | ||
| Profit Quality | 220.39% | ||
| Current Ratio | 6.8 | ||
| Quick Ratio | 2.94 | ||
| Altman-Z | 25.99 |
F-Score6
WACC8.7%
ROIC/WACC0.59
Cap/Depr(3y)171.65%
Cap/Depr(5y)178.27%
Cap/Sales(3y)13.72%
Cap/Sales(5y)13.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.54%
EPS 3Y-14.81%
EPS 5Y-9.39%
EPS Q2Q%-93.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6%
Revenue growth 3Y4.68%
Revenue growth 5Y2.13%
Sales Q2Q%11.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.38%
EBIT growth 3Y-14.16%
EBIT growth 5Y-11.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.73%
OCF growth 3Y-20.1%
OCF growth 5Y-14.29%